Apogee Therapeutics CEO Michael Thomas Henderson disposes of USD 2.67 million in common shares
A
APGE• CEO reduces stake through two share transactions
- Apogee Therapeutics CEO Michael Thomas Henderson cut his stake through a 20,000-share sale on July 8 at USD 133.63.
•
Apogee Therapeutics CEO Michael Thomas Henderson disposes of USD 2.67 million in common shares - APGE News | Rallies
